#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Parkinson's disease Drug eruption Chronic cutaneous lupus erythematosus Dedifferentiated liposarcoma Cognitive disorder Malignant central nervous system neoplasm Mantle cell lymphoma stage IV Chemical burn Acquired haemophilia Progressive familial intrahepatic cholestasis Haemophilia Marginal zone lymphoma recurrent Hodgkin's disease refractory Cutaneous T-cell lymphoma refractory Philadelphia positive chronic myeloid leukaemia More trials…

    Learn about Rare Diseases

    Waldenstrom’s macroglobulinaemia – Trials in Disease Mucopolysaccharidosis II – Treatment Sarcoidosis – Trials in Disease Ehlers-Danlos syndrome – Diagnostics Breast angiosarcoma Glycogen storage disease type II – Life with Disease Mast cell activation syndrome – Diagnostics Erdheim-Chester disease – Trials in Disease Congenital hypotransferrinaemia – Basic Information Sarcoma – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Vortioxetine Hydrobromide Cedazuridine Ulotaront Bexotegrast Levamlodipine Succinate Giredestrant Irinotecan Tedizolid Phosphate Clomipramine Hydrochloride Capecitabine OBI-821 Inotuzumab Ozogamicin Plerixafor Sodium Iodide (123 I) Hydroxi-Methionine Calcium 12 Grass Pollen Mixture Famotidine ZIGAKIBART Molgramostim Dapagliflozin Propanediol More therapies…

    Learn about Your Condition

    Obsessive-compulsive disorder Colonoscopy Heart disease congenital Dermatomyositis Laparoscopic surgery Bone hypertrophy Asthma Mantle cell lymphoma recurrent Pleomorphic leiomyosarcoma Escherichia infection Death neonatal Endometrial cancer stage IV Renal cell carcinoma Lichen sclerosus Acute myocardial infarction More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Pulmonary embolism

  • Study on Rosuvastatin for Reducing Blood Clots in Patients with Deep Vein Thrombosis or Pulmonary Embolism

    Recruiting

    3 1 1
    Investigated Diseases:
    • Deep vein thrombosis
    • Deep vein thrombosis postoperative
    • Pelvic venous thrombosis
    Investigated Drugs:
    • Rosuvastatin Calcium
    France Norway

  • Study on the Effectiveness of Oxygen for Patients with Intermediate-Risk Acute Pulmonary Embolism

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Pulmonary embolism
    Investigated Drugs:
    • Oxygen
    Italy Spain

  • Study on Monitoring vs. Rivaroxaban for Patients with Low-Risk Isolated Subsegmental Pulmonary Embolism

    Recruiting

    3 1 1
    Investigated Drugs:
    • Rivaroxaban
    Belgium France The Netherlands

  • Study on the Best Antithrombotic Therapy for Patients with Acute Venous Thromboembolism Using Tinzaparin Sodium and Drug Combination

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Acenocoumarol
    • D,L-Lysine Acetylsalicylate
    • Fondaparinux Sodium
    France

  • Study on Treatments for Intermediate High-Risk Pulmonary Embolism: Comparing Percutaneous Embolectomy, Ultrasound-Assisted Thrombolysis with Alteplase, and Heparin

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Heparin
    • Tinzaparin Sodium
    • Alteplase
    Denmark

  • Enoxaparin or drug combination versus no anticoagulant treatment for incidental subsegmental pulmonary embolism in cancer patients

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Pulmonary embolism
    Investigated Drugs:
    • Tinzaparin Sodium
    • Lactose Monohydrate
    • Apixaban
    Denmark
1 2 3
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!